SCHEMBL819289

SCHEMBL819289

CC(=O)/C=C\C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15286797 1.00 TSHR (0.64)
SCHEMBL106343 1.00
SCHEMBL15286796 1.00 TSHR (0.64)
SCHEMBL163093 1.00
Hydrochloric Acid SCHEMBL27974252 0.97
Acrylic Acid SCHEMBL1082039 0.88 LMNA (0.56)
Fumaric Acid SCHEMBL15689651 0.85 TSHR (0.75)
Maleic Acid SCHEMBL8032158 0.85 TSHR (0.75)
Fumaric Acid SCHEMBL289218 0.85 TSHR (0.75)
Fumaric Acid SCHEMBL3825816 0.85 TSHR (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577526-B2 Massively parallel on-chip construction of synthetic microbial communities THE BROAD INSTITUTE, INC. (US) 2026-03-17 US disclosed
US-20250376656-A1 MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-12-11 US disclosed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US disclosed
US-20240025920-A1 SALT FORM USED AS CDC7 INHIBITOR AND CRYSTAL FORM THEREOF CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-01-25 US disclosed
US-20240016735-A1 IONIC LIQUIDS FOR DRUG DELIVERY PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-01-18 US disclosed
US-20230357640-A1 Compositions Comprising Water Dispersible Polymer and Unsaturated Dicarboxylic Acid Derivative Suitable for Enhancing Char 3M INNOVATIVE PROPERTIES COMPANY 2023-11-09 US disclosed
US-20230322687-A1 SALT OF ARYLAMINOQUINAZOLINE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) 2023-10-12 US disclosed
US-20230257337-A1 METHOD FOR PRODUCING POLYGYLCEROL ESTERS OF POLYCARBOXYLIC ACIDS ESTERIFIED WITH OXOBUTANOL KETOLIPIX THERAPEUTICS GMBH (DE) 2023-08-17 US disclosed
US-20230227314-A1 CARBON NANOSTRUCTURE COMPOSITIONS AND METHODS FOR PURIFICATION THEREOF NANO-C, INC. 2023-07-20 US disclosed
US-20230227687-A1 KETONE FUNCTIONALIZED POLYMERS, METHODS OF MAKING KETONE FUNCTIONALIZED POLYMERS, AND COMPOSITIONS INCLUDING THE SAME ENNIS-FLINT, INC. (US) 2023-07-20 US disclosed
US-20070197731-A1 Process for producing thermoplastic resin composition SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-23 US disclosed
US-RE39794-E1 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives DAVY PROCESS TECHNOLOGY LIMITED (GB) 2007-08-21 US disclosed
US-7250521-B2 Method for production of Δ1-pyrrolines BAYER CROPSCIENCE AKTIENGESELLSCHAFT 2007-07-31 US disclosed
US-20070172753-A1 Photosensitive resin composition and manufacturing method of semiconductor device using the same FUJIFILM CORPORATION (JP) 2007-07-26 US disclosed
US-7238455-B2 Mixture of alkali soluble resin, quinonediazide compound and alcohol SUMITOMO BAKELITE COMPANY, LTD. (JP) 2007-07-03 US disclosed
US-20070141021-A1 Methylmaleimidyl polymer derivatives SUN BIO, INC. 2007-06-21 US disclosed
US-7230096-B2 Inhibitors against galectins FORSKARPATENT I SYD AB (SE) 2007-06-12 US disclosed
US-7230096-B2 Inhibitors against galectins FORSKARPATENT I SYD AB (SE) 2007-06-12 US disclosed
US-20070129565-A1 Process for the production of esters of mono-, di- or polycarboxylic acids DAVY PROCESS TECHNOLOGY LIMITED (GB) 2007-06-07 US disclosed
US-20070049688-A1 Method for preparing polymer maleimides NEKTAR THERAPEUTICS 2007-03-01 US disclosed